FOXO4-DRI

Preclinical

FOXO4-D-Retro-Inverso Peptide

Aliases
FOXO4-DRI, Proxofim
Administration
Subcutaneous injection (preclinical/animal research only)

Documented side effects

Tier 1 · Peer-reviewed / regulatory

No human safety data yet — animal studies only

This compound has not been tested in humans, so no human side-effect data currently exists.

Long-term safety still under study

This compound is newer to human research, and its long-term safety profile is still being established.